Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Biocryst Pharmaceuticals Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 319
- +19 vs. Q1 2026
- Shares held
- 261.6M
- +21.2M (+8.8%) vs. Q1 2026
- Total value
- $2.61B
- +$326.8M (+14.3%) vs. Q1 2026
- New holders
- 56
- 132 more added
- Sold out
- 37
- 88 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.61B |
| Q1 2026 | 303 | $2.37B |
| Q4 2025 | 273 | $1.66B |
| Q3 2025 | 286 | $1.47B |
| Q2 2025 | 294 | $1.77B |
| Q1 2025 | 274 | $1.32B |
| Q4 2024 | 258 | $1.26B |
| Q3 2024 | 257 | $1.32B |
| Q2 2024 | 242 | $1.08B |
| Q1 2024 | 238 | $915.0M |
| Q4 2023 | 236 | $1.06B |
| Q3 2023 | 233 | $1.24B |
| Q2 2023 | 236 | $1.23B |
| Q1 2023 | 242 | $1.42B |
| Q4 2022 | 230 | $1.80B |
| Q3 2022 | 234 | $1.87B |
| Q2 2022 | 221 | $1.61B |
| Q1 2022 | 233 | $2.07B |
| Q4 2021 | 206 | $1.63B |
| Q3 2021 | 197 | $1.48B |
| Q2 2021 | 195 | $1.65B |
| Q1 2021 | 191 | $1.06B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Biocryst Pharmaceuticals Inc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 3,394,729 | $33.9M | 0.02% | +3,207,008+1,708.4% | Added |
| Nuveen, LLC | 4,007,237 | $40.1M | 0.01% | +187,974+4.9% | Added |
| Frazier Life Sciences Management, L.P. | 4,009,240 | $40.1M | 0.87% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 4,481,874 | $44.8M | 0.00% | +2,134,431+90.9% | Added |
| Bank of America Corp | 4,801,284 | $48.0M | 0.00% | −290,481−5.7% | Reduced |
| UBS Group AG | 5,078,280 | $50.8M | 0.01% | +134,286+2.7% | Added |
| Standard Life Aberdeen plc | 5,310,871 | $53.1M | 0.07% | +270,201+5.4% | Added |
| Geode Capital Management, LLC | 6,248,046 | $62.5M | 0.00% | +465,270+8.0% | Added |
| Two Sigma Investments, LP | 6,775,349 | $67.8M | 0.05% | +382,721+6.0% | Added |
| Vestal Point Capital, LP | 8,300,000 | $83.0M | 1.94% | +1,275,000+18.1% | Added |
| Jupiter Topco LLC | 9,540,764 | $95.3M | 0.04% | +9,540,764 | New |
| Perceptive Advisors LLC | 10,308,888 | $103.1M | 1.60% | +2,874,855+38.7% | Added |
| TCG Crossover Management, LLC | 11,020,968 | $110.2M | 2.65% | 00.0% | Unchanged |
| Vanguard Portfolio Management LLC | 11,139,158 | $111.4M | 0.01% | −105,467−0.9% | Reduced |
| Vanguard Capital Management LLC | 11,364,236 | $113.6M | 0.00% | +228,474+2.1% | Added |
| Deerfield Management Company, L.P. (Series C) | 15,096,403 | $151.0M | 1.57% | +58,403+0.4% | Added |
| State Street Corp | 15,191,098 | $151.9M | 0.00% | +2,982,738+24.4% | Added |
| Ra Capital Management, L.P. | 15,827,186 | $158.3M | 1.38% | 00.0% | Unchanged |
| BlackRock, Inc. | 23,893,036 | $238.9M | 0.00% | +1,242,048+5.5% | Added |
| Royalty Pharma Sub-Manager, LLC | 0 | $0 | 0.00% | −3,846,154−100.0% | Sold out |
| RFG Advisory, LLC | 0 | $0 | 0.00% | −2,870,700−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −1,004,373−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −639,100−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −202,900−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −186,125−100.0% | Sold out |
| University of Texas/Texas Am Investment Managment Co | 0 | $0 | 0.00% | −90,977−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −88,876−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −87,010−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −82,100−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −78,103−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −75,908−100.0% | Sold out |
| Integrated Quantitative Investments LLC | 0 | $0 | 0.00% | −65,365−100.0% | Sold out |
| Vinva Investment Management Ltd | 0 | $0 | 0.00% | −40,321−100.0% | Sold out |
| Navellier & Associates Inc | 0 | $0 | 0.00% | −45,286−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −41,165−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −40,889−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −29,554−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −27,000−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Bender Robert & Associates | 0 | $0 | 0.00% | −23,710−100.0% | Sold out |
| Polymer Capital Management (US) LLC | 0 | $0 | 0.00% | −21,353−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −20,649−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −20,567−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −20,422−100.0% | Sold out |
| Aviva PLC | 0 | $0 | 0.00% | −15,695−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −14,908−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −11,654−100.0% | Sold out |
| Hilltop Holdings Inc. | 0 | $0 | 0.00% | −10,310−100.0% | Sold out |
| 1620 Investment Advisors, Inc. | 0 | $0 | 0.00% | −1,180−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −705−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −699−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −428−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −427−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −302−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| Deeter Investments LLP | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |